Qingguo Li

2.0k total citations
46 papers, 1.5k citations indexed

About

Qingguo Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qingguo Li has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Qingguo Li's work include Colorectal Cancer Surgical Treatments (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Colorectal and Anal Carcinomas (9 papers). Qingguo Li is often cited by papers focused on Colorectal Cancer Surgical Treatments (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Colorectal and Anal Carcinomas (9 papers). Qingguo Li collaborates with scholars based in China, United States and Norway. Qingguo Li's co-authors include Xinxiang Li, Sanjun Cai, Ye Xu, Dakui Luo, Qi Liu, Weijing He, Decai Yu, Weixing Dai, Guoxiang Cai and Xiwei Ding and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Qingguo Li

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingguo Li China 23 849 691 396 192 189 46 1.5k
Lui Ng Hong Kong 19 805 0.9× 651 0.9× 676 1.7× 314 1.6× 151 0.8× 45 1.6k
Lili Liu China 22 1.1k 1.3× 885 1.3× 347 0.9× 145 0.8× 192 1.0× 58 1.7k
Jun Song China 23 990 1.2× 675 1.0× 449 1.1× 138 0.7× 152 0.8× 69 1.6k
Wenfeng Cao China 22 947 1.1× 456 0.7× 396 1.0× 102 0.5× 225 1.2× 59 1.6k
Danilo Fiore Italy 16 898 1.1× 776 1.1× 216 0.5× 108 0.6× 225 1.2× 26 1.5k
Xiaodong Tan China 24 881 1.0× 599 0.9× 555 1.4× 158 0.8× 272 1.4× 88 1.5k
Bernardo Tavora United Kingdom 14 921 1.1× 528 0.8× 259 0.7× 129 0.7× 226 1.2× 16 1.4k
Xinbao Hao China 14 1.3k 1.5× 835 1.2× 506 1.3× 124 0.6× 117 0.6× 35 1.8k
Yitian Chen China 18 583 0.7× 424 0.6× 466 1.2× 113 0.6× 223 1.2× 45 1.3k
Esther Bridges United Kingdom 21 1.1k 1.3× 744 1.1× 430 1.1× 80 0.4× 130 0.7× 38 1.7k

Countries citing papers authored by Qingguo Li

Since Specialization
Citations

This map shows the geographic impact of Qingguo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingguo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingguo Li more than expected).

Fields of papers citing papers by Qingguo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingguo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingguo Li. The network helps show where Qingguo Li may publish in the future.

Co-authorship network of co-authors of Qingguo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qingguo Li. A scholar is included among the top collaborators of Qingguo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingguo Li. Qingguo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Qi, Yajuan Zhang, Huimin Li, et al.. (2024). Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Communication and Signaling. 22(1). 278–278. 8 indexed citations
3.
Zhang, Shanshan, Yang Zhu, Jiangwei Chen, et al.. (2024). COF-5/Pebax mixed-matrix membranes with enhanced CO2 removal ability for ECCO2R system. Separation and Purification Technology. 358. 130399–130399. 2 indexed citations
4.
Luo, Dakui, Min Chen, Qingguo Li, et al.. (2023). CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. Experimental Hematology and Oncology. 12(1). 77–77. 13 indexed citations
5.
Han, Lingyu, Weixing Dai, Wenqin Luo, et al.. (2023). Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer. Cancers. 15(3). 562–562. 14 indexed citations
6.
Dai, Weixing, Wenqiang Xiang, Lingyu Han, et al.. (2022). PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Communications. 42(9). 848–867. 69 indexed citations
7.
Yang, Yufei, Dakui Luo, Yang Shao, et al.. (2022). circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer. Cancer Communications. 43(1). 100–122. 46 indexed citations
8.
Li, Qingguo, Huizhen Sun, Dakui Luo, et al.. (2021). Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. Journal of Experimental & Clinical Cancer Research. 40(1). 348–348. 61 indexed citations
9.
Dai, Weixing, Ye Xu, Shaobo Mo, et al.. (2020). GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies. Signal Transduction and Targeted Therapy. 5(1). 177–177. 90 indexed citations
10.
Wang, Renjie, Wenqiang Xiang, Ye Xu, et al.. (2020). Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential. Annals of Translational Medicine. 8(6). 302–302. 22 indexed citations
13.
Liu, Qi, Dakui Luo, S. Zhang, et al.. (2019). Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer. Journal of Cancer. 10(5). 1209–1215. 12 indexed citations
14.
Liu, Qi, Yanlei Ma, Dakui Luo, et al.. (2018). Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer. International Journal of Colorectal Disease. 33(8). 1107–1114. 7 indexed citations
15.
Li, Qingguo, Ping Wei, Jitao Wu, et al.. (2018). The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect. Oncogene. 38(4). 483–496. 49 indexed citations
16.
Li, Qingguo, Yaqi Li, Junyan Xu, et al.. (2017). Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma. Cellular Physiology and Biochemistry. 42(1). 397–406. 54 indexed citations
17.
Li, Qingguo, Yi Qin, Ping Wei, et al.. (2016). Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Molecular Cancer Research. 14(9). 830–840. 50 indexed citations
18.
Cai, Xin, et al.. (2016). Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. Acta Biochimica et Biophysica Sinica. 49(2). 119–127. 52 indexed citations
19.
Zhuo, Changhua, Ye Xu, Mingang Ying, et al.. (2015). FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer. Immunologic Research. 61(3). 338–347. 60 indexed citations
20.
Wang, Hui, et al.. (2000). Primary structure of helix C to helix G of a new retinal protein in H.sp.xz515. Chinese Science Bulletin. 45(12). 1108–1113. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026